Last reviewed · How we verify
Potassium Acetate
Potassium Acetate is a small molecule drug originally developed by B BRAUN and currently owned by Hospira. It is FDA-approved for the treatment of hypokalemia and prevention of hypokalemia. The commercial status of Potassium Acetate is off-patent, with two generic manufacturers available. Key safety considerations include the potential for hyperkalemia, a condition characterized by elevated potassium levels in the blood. As an off-patent medication, Potassium Acetate is widely available and used to treat hypokalemia.
At a glance
| Generic name | Potassium Acetate |
|---|---|
| Sponsor | Pfizer |
| Drug class | potassium acetate |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
| First approval | 1971 |
Approved indications
- Hypokalemia
- Hypokalemia Prevention
Common side effects
- Cardiac arrest
- Cardiac arrhythmias
- Heart block
- Electrocardiographic abnormalities
- Muscular or respiratory paralysis
- Areflexia
- Paresthesias of the extremities
- Mental confusion
- Weakness
- Hypotension
- Respiratory depression
- Circulatory collapse
Drug interactions
- quinapril
- ramipril
- spironolactone
- triamterene
Key clinical trials
- Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PHASE3)
- Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery (PHASE3)
- Clinical Effects of Ringers Lactate Versus Sterofundin/ Plasmalyte Solution in Patients With Sepsis (NA)
- Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Disease Undergoing Hemodialysis (NA)
- A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health (NA)
- The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age (NA)
- Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia
- A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Potassium Acetate CI brief — competitive landscape report
- Potassium Acetate updates RSS · CI watch RSS
- Pfizer portfolio CI